1. Home Page
  2. For Cancer Researchers
  3. Clinical Research
  4. Clinical Research Areas
  5. CNS Malignancy
  6. Who We Are
CNS Malignancy

Who We Are

At the OSUCCC – James, a multidisciplinary team of researchers are dedicated to developing and conducting leading-edge research that advances innovative breakthroughs and treatments for patients with central nervous system (CNS) malignancies.

    The OSUCCC – James CNS Malignancies Clinical Research Program team members include world-renowned specialists and sub-specialists in the prevention, diagnosis, genetic sequencing and treatment of central nervous system malignancies and other brain- and spine-related diseases.

    This team of experts comprises talented individuals from a multicultural background who strive to reach the highest accomplishment levels, seamlessly translating research to the clinic.

    CNS Malignancy Clinical Research Faculty

    Robert A Baiocchi, MD, PhD
    I am a medical oncologist who treats patients with blood cancers.
    Arnab Chakravarti, MD
    I am a professor and chair of the Department of Radiation Oncology at The Ohio State University College of Medicine.
    Tim Cripe, MD, PhD
    I am a professor of Pediatrics at The Ohio State University, chief of the Division of Hematology/Oncology/BMT at Nationwide Children's Hospital, and a member of the Translational Therapeutics Program at the OSUCCC – James.
    Nicholas Charles Denko, MD, PhD
    I am a member of the Cancer Biology Program at the OSUCCC – James and the co-holder of two U.S. patents related to medical research.
    Deliang Guo, PhD
    I am a professor in the Department of Radiation Oncology at The Ohio State University and a member of the Translational Therapeutics Program at the OSUCCC – James, where my work is focused on determining the key molecular targets in cancer metabolism and translating those findings into the clinical setting.
    Russell R Lonser, MD
    I am a neurological surgeon who specializes in the resection of brain, spinal cord, pituitary and brainstem tumors.
    Jose J Otero, MD, PhD
    I am a member of the Cancer Biology Program at the OSUCCC – James, where my research focuses on induced pluripotent stem cells, neural stem cells, cell-cycle control of stem cells and molecular diagnostics.
    Kamalakannan Palanichamy, PhD
    Through my research as a member of the Translational Therapeutics Program at the OSUCCC – James, I seek to explore transcriptomic, epigenetic, metabolomics, proteomic and genomic profiles of patient biopsies in order to identify the mechanisms of chemo and radiation resistance in treatment refractory tumors.